Jill Schwartz, MD
CONRAD
6
0
5
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+2 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (6)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Chris Mauck, MD
CONRAD
Shared therapeutic areas:
Worked with same sponsors:
Pablo Tebas, MD
University of Pennsylvania
Shared therapeutic areas:
François Raffi, PHD
Hopital Hotel Dieu Nantes
Shared therapeutic areas:
Gilles Pichancourt
CH Henri Duffaut Avignon
Shared therapeutic areas:
Bruno Marchou, PHD
CHU Purpan (Toulouse)
Shared therapeutic areas:
Jean Luc Schmit
Hôpital Nord Amiens
Shared therapeutic areas:
André Cabié
CHU Fort de France
Shared therapeutic areas:
Antoine Chéret
CH TOURCOING
Shared therapeutic areas:
JP Viard, MD
Hotel Dieu Paris
Shared therapeutic areas:
Daniel Sereni, PHD
St Louis ¨Paris
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (6)
Showing 6 of 6 trials
Pharmacokinetic Study of the Vaginal Microbicide Agent 1% Tenofovir Gel
Safety, Pharmacokinetics, Pharmacodynamics, and Disintegration Time of Vaginal Tablets Containing Tenofovir and/or Emtricitabine
Phase I One-month Safety, PK, PD, and Acceptability Study of IVR Releasing TFV and LNG or TFV Alone
Safety and Acceptability of Tenofovir 1% Gel in Adolescent Females
Assessing the Disintegration, Safety, and Acceptability of Placebo Vaginal Inserts for the Delivery of Vaginal Products
All 6 trials loaded